Your shopping cart is currently empty

Incensole acetate is a natural product and TRPV3 agonist that induces calcium influx in HEK293 cells expressing TRPV3 channels. It modifies c-Fos activation in the mouse brain, exhibits anti-anxiety effects, and possesses anti-inflammatory properties.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $52 | In Stock | In Stock | |
| 5 mg | $110 | In Stock | In Stock | |
| 10 mg | $190 | - | In Stock | |
| 25 mg | $379 | - | In Stock | |
| 50 mg | $569 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $85 | - | In Stock |
| Description | Incensole acetate is a natural product and TRPV3 agonist that induces calcium influx in HEK293 cells expressing TRPV3 channels. It modifies c-Fos activation in the mouse brain, exhibits anti-anxiety effects, and possesses anti-inflammatory properties. |
| Targets&IC50 | HEK293 cells:2.2 μM |
| In vitro | Methods: To investigate the preventive effects on Aβ25-35-induced neurotoxicity in homo sapiens olfactory bulb neural stem cells (hOBNSCs), hOBNSCs were pretreated with Incensole acetate (100 μM) for 4 hours prior to Aβ25-35 treatment. Cell viability was assessed using the MTT assay.
Results: Aβ25-35 significantly reduced cell viability, whereas Incensole acetate pretreatment markedly restored cell viability.[1] |
| Molecular Weight | 348.52 |
| Formula | C22H36O3 |
| Cas No. | 34701-53-6 |
| Smiles | CC(C)[C@@]12CC[C@@](C)(O1)[C@H](CC\C(C)=C\CC\C(C)=C\C2)OC(C)=O |
| Relative Density. | 0.99 g/cm3 (Predicted) |
| Storage | keep away from direct sunlight,keep away from moisture,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (229.54 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (9.47 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.